Text Size

Evaluation of Isostretching Effects in Patients With Mechanical and Postural Chronic Low Back Pain

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2011 by Federal University of São Paulo.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by:
Federal University of São Paulo
ClinicalTrials.gov Identifier:
NCT01314157
First received: March 11, 2011
Last updated: NA
Last verified: February 2011
History: No changes posted
  Purpose

Isostretching is effective in treating chronic back pain to improve pain, quality of life and functional capacity.


Condition Intervention
Chronic Low Back Pain
 Other: Isostretching

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Investigator)
Primary Purpose: Supportive Care
Official Title: Evaluation of Isostretching Effects in Patients With Mechanical and Postural

Resource links provided by NLM:

MedlinePlus related topics: Back Pain
U.S. FDA Resources

Further study details as provided by Federal University of São Paulo:

Primary Outcome Measures:
  • Evaluation of isostretching effects in patients with chronic low back pain [ Time Frame: 1 month ] [ Designated as safety issue: No ]
    Reviewed by analog pain scale. (VAS)


Estimated Enrollment: 54
Study Start Date: March 2011
Estimated Primary Completion Date: June 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Physiotherapy treatment technique
Randomized clinical trial controlling and using at the time of allocation, toss with sealed envelopes, sealed and opaque. The study group will be dealt with "technical isostretching" and the other group is control group.
 Other: Isostretching
12 interventions (two times per week) for 45 minutes
Other Name: Strengthening and stretching exercise during expiration.

  Eligibility

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Individuals diagnosed with chronic low back pain with pain located between the last rib and the gluteal fold over 12 weeks;
  • Mechanical back pain that worsens with exertion and relieved by rest;
  • Pain between 3 and 8 cm measured by analog pain scale.

Exclusion Criteria:

  • Subjects who presented pain root
  • Fibromyalgia
  • Severe scoliosis with abnormal alignment of the spine (Cobb angle> 40); Tumors in the column; Infiltration in the lumbar spine in the last three months; Previous surgery of the spine (patients return to work or process expulsion)
  • Have changed or initiated physical activity in the last three months
  • Body mass index greater than 30 kg/m2
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01314157

Contacts
Contact: Erika Rosângela A Prado, Specialist + 55 82 93137483 ext - conecterikaprado@hotmail.com
Contact: Jamil Natour, Phd + 55 11 55798087 ext - jnatour@unifesp.br

Locations
Brazil
Erika Rosangela Alves Prado Not yet recruiting
Maceió, Alagoas, Brazil, 57051-540
Contact: Renata S Soutinho, Specialist     +55 85 32155124 ext 5124     renatasampaio_@hotmail.com    
Sponsors and Collaborators
Federal University of São Paulo
Investigators
Principal Investigator: Erika Rosângela A Prado, Specialist Universidade Estadual de Ciências da Saúde de Alagoas
  More Information

No publications provided

Responsible Party: Erika Rosângela Alves Prado, Federal University of São Paulo
ClinicalTrials.gov Identifier: NCT01314157     History of Changes
Other Study ID Numbers: 1-Prado
Study First Received: March 11, 2011
Last Updated: March 11, 2011
Health Authority: Brazil: Ethics Committee

Keywords provided by Federal University of São Paulo:
low back pain
pain
incapacity
life quality
rehabilitation

Additional relevant MeSH terms:
Back Pain
Low Back Pain
Pain
 Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms

ClinicalTrials.gov processed this record on May 23, 2013